JVLIX | VIVAX | JVLIX / VIVAX | |
Total Expense Ratio | 0.71 | 0.17 | 418% |
Annual Report Gross Expense Ratio | 0.72 | 0.17 | 424% |
Fund Existence | 28 years | 33 years | - |
Gain YTD | 3.697 | 2.419 | 153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.4B | 189B | 9% |
Annual Yield % from dividends | 0.98 | 2.16 | 46% |
Returns for 1 year | -2.95 | 8.01 | -37% |
Returns for 3 years | 12.20 | 32.20 | 38% |
Returns for 5 years | 41.30 | 72.56 | 57% |
Returns for 10 years | 28.27 | 103.54 | 27% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SKRE | 13.49 | 0.74 | +5.80% |
Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF | |||
TZA | 13.24 | 0.69 | +5.50% |
Direxion Daily Small Cap Bear 3X ETF | |||
RA | 12.88 | N/A | N/A |
Brookfield Real Assets Income Fund | |||
XBI | 83.60 | -0.76 | -0.90% |
SPDR® S&P Biotech ETF | |||
DVAL | 13.73 | -0.14 | -1.01% |
BrandywineGLOBAL Dyn US Lrg Cap Val ETF |